ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

FDA Proposal To Regulate Tobacco Wins Support Of NCI, Oncology Societies

September 8, 1995

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

Bush Proposes 16 Percent Increase For NIH, To Complete Budget Doubling.

February 1, 2002

ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions

October 11, 2002